BAIARDI, SIMONE
 Distribuzione geografica
Continente #
AS - Asia 4.271
NA - Nord America 3.869
EU - Europa 2.635
SA - Sud America 284
AF - Africa 162
OC - Oceania 6
Totale 11.227
Nazione #
US - Stati Uniti d'America 3.799
SG - Singapore 1.427
CN - Cina 1.134
IT - Italia 949
VN - Vietnam 730
HK - Hong Kong 376
GB - Regno Unito 375
DE - Germania 292
SE - Svezia 235
KR - Corea 223
BR - Brasile 193
NL - Olanda 171
IN - India 153
RU - Federazione Russa 116
IE - Irlanda 104
FR - Francia 91
FI - Finlandia 81
SC - Seychelles 56
ID - Indonesia 53
JP - Giappone 50
CI - Costa d'Avorio 43
BG - Bulgaria 42
AR - Argentina 38
ZA - Sudafrica 38
CA - Canada 32
UA - Ucraina 32
MX - Messico 29
JO - Giordania 27
AT - Austria 25
TR - Turchia 23
EC - Ecuador 22
EE - Estonia 22
DK - Danimarca 17
ES - Italia 16
PL - Polonia 14
BD - Bangladesh 12
BE - Belgio 11
CH - Svizzera 10
CO - Colombia 9
IQ - Iraq 9
PK - Pakistan 9
IL - Israele 7
UZ - Uzbekistan 7
GR - Grecia 6
LT - Lituania 6
MA - Marocco 6
TG - Togo 6
VE - Venezuela 6
AU - Australia 5
CL - Cile 5
PY - Paraguay 5
DO - Repubblica Dominicana 4
KH - Cambogia 4
NG - Nigeria 4
AE - Emirati Arabi Uniti 3
IR - Iran 3
LB - Libano 3
LU - Lussemburgo 3
LV - Lettonia 3
SA - Arabia Saudita 3
TH - Thailandia 3
UY - Uruguay 3
AM - Armenia 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CG - Congo 2
GT - Guatemala 2
HR - Croazia 2
HU - Ungheria 2
MY - Malesia 2
PE - Perù 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
AO - Angola 1
BZ - Belize 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EG - Egitto 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
QA - Qatar 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
TN - Tunisia 1
Totale 11.227
Città #
Singapore 1.012
Ashburn 498
Hefei 492
Hong Kong 372
Fairfield 359
Southend 300
Chandler 289
Bologna 249
Dallas 223
Seoul 222
Dong Ket 187
Woodbridge 173
Seattle 155
Houston 147
Ho Chi Minh City 143
Cambridge 131
Wilmington 131
Beijing 125
Santa Clara 110
Dublin 104
Princeton 104
Hanoi 102
Redmond 96
Ann Arbor 95
Boardman 87
Turin 77
Los Angeles 70
Milan 53
Bengaluru 50
Redondo Beach 50
Tokyo 45
Abidjan 43
Florence 43
Lappeenranta 42
Berlin 41
Sofia 40
Jakarta 37
New York 37
Westminster 34
Helsinki 32
Imola 31
Amman 27
Chicago 27
Nanjing 27
Nuremberg 27
Buffalo 26
Frankfurt am Main 23
Rome 23
São Paulo 21
Boydton 20
Jinan 20
Padova 20
Haiphong 19
Amsterdam 18
Phoenix 16
San Diego 16
Biên Hòa 14
Guangzhou 14
London 14
Mexico City 14
Vienna 14
Da Nang 13
Falkenstein 13
Falls Church 13
Shenyang 13
Tongling 13
Verona 13
Tianjin 12
Des Moines 11
Forlì 11
Munich 11
Shanghai 11
Brussels 10
Changsha 10
Genoa 10
Istanbul 10
Montreal 10
Quito 10
Stockholm 10
Toronto 10
Yubileyny 10
Bergamo 9
Can Tho 9
Hebei 9
Olalla 9
Orem 9
Quận Một 9
Redwood City 9
Saint Petersburg 9
San Francisco 9
Council Bluffs 8
Medford 8
Perugia 8
Trento 8
Ankara 7
Bern 7
Brasília 7
Brooklyn 7
Chennai 7
Hải Dương 7
Totale 7.410
Nome #
Cerebrospinal fluid biomarkers of neurodegeneration in narcolepsy type 1 380
Cognitive rehabilitation and transcranial direct current stimulation in a patient with posterior cortical atrophy: An fMRI study 238
High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions 206
Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease 198
CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia 195
Chronobiology, sleep-related risk factors and light therapy in perinatal depression: The "Life-ON" project 193
Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden 183
A restless abdomen and propriospinal myoclonus like at sleep onset: an unusual overlap syndrome. 178
Atypical Creutzfeldt-Jakob disease with PrP-amyloid plaques in white matter: molecular characterization and transmission to bank voles show the M1 strain signature 178
Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and A$\upbeta$42 levels 174
Characterization of novel progranulin gene variants in Italian patients with neurodegenerative diseases 174
Cognitive profile in idiopathic autonomic failure: relation with white matter hyperintensities and neurofilament levels 170
Cataplectic attacks during rapid eye movement sleep behavior disorder episodes in a narcoleptic patient. 169
Clinical Reasoning: Rapidly progressive dementia in a patient with HIV after an exotic journey 169
Two novel PRNP truncating mutations broaden the spectrum of prion amyloidosis 161
Identification of rare genetic variants in Italian patients with dementia by targeted gene sequencing 160
Clinical effects of Lewy body pathology in cognitively impaired individuals 159
In vivo assessment of Lewy body and beta-amyloid copathologies in idiopathic normal pressure hydrocephalus: prevalence and associations with clinical features and surgery outcome 159
Detection of prions in skin punch biopsies of Creutzfeldt–Jakob disease patients 158
Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes 154
The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins 152
Elevated plasma p-tau181 levels unrelated to Alzheimer's disease pathology in amyotrophic lateral sclerosis 150
Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias 149
Antemortem CSF Aβ42/Aβ40 ratio predicts Alzheimer's disease pathology better than Aβ42 in rapidly progressive dementias 146
Sporadic Fatal Insomnia in Europe: Phenotypic features and diagnostic challenges 145
CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson’s disease 142
Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease 142
Genomic, transcriptomic and RNA editing analysis of human MM1 and VV2 sporadic Creutzfeldt-Jakob disease 141
Clinicopathological features of the rare form of Creutzfeldt-Jakob disease in R208H-V129V PRNP carrier 138
Revisiting the Heidenhain Variant of Creutzfeldt-Jakob Disease: Evidence for Prion Type Variability Influencing Clinical Course and Laboratory Findings 137
Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt-Jakob Disease in the Clinical Setting of Rapidly Progressive Dementia 136
Towards an early clinical diagnosis of sporadic CJD VV2 (ataxic type) 136
Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies 136
Is the Epworth Sleepiness Scale a useful tool for screening excessive daytime sleepiness in commercial drivers? 135
Identification of recurrent genetic patterns from targeted sequencing panels with advanced data science: a case-study on sporadic and genetic neurodegenerative diseases 134
Unusual Clinical Presentations Challenging the Early Clinical Diagnosis of Creutzfeldt-Jakob Disease 133
Narcolepsy Type 1 and Idiopathic Generalized Epilepsy: Diagnostic and Therapeutic Challenges in Dual Cases 130
In vivo detection of Alzheimer's and Lewy body disease concurrence: Clinical implications and future perspectives 123
Sleep and sleep disorders during pregnancy and postpartum: The Life-ON study 123
Towards an improved early diagnosis of neurodegenerative diseases: The emerging role of in vitro conversion assays for protein amyloids 120
Alpha-synuclein seed amplification assay longitudinal outcomes in Lewy body disease spectrum 117
Amyloid-Beta Co-Pathology Is a Major Determinant of the Elevated Plasma GFAP Values in Amyotrophic Lateral Sclerosis 117
Levels of plasma brain‐derived tau and p‐tau181 in Alzheimer's disease and rapidly progressive dementias 117
Immunotherapy of oneiric stupor in Morvan syndrome: Efficacy documented by actigraphy 114
Depressive Symptoms and Amyloid Pathology 113
Clinical value of novel blood-based tau biomarkers in Creutzfeldt–Jakob disease 112
Sleep-readiness signals in insomniacs and good sleepers 112
Understanding prion strains: Evidence from studies of the disease forms affecting humans 112
Validation of Revised International Creutzfeldt-Jakob Disease Surveillance Network Diagnostic Criteria for Sporadic Creutzfeldt-Jakob Disease 111
Diagnostic value of surrogate CSF biomarkers for Creutzfeldt–Jakob disease in the era of RT-QuIC 110
Recent advances in the histo-molecular pathology of human prion disease 108
Influence of chronotype on the incidence and severity of perinatal depression in the "Life-ON" study 107
Improving protocols for α-synuclein seed amplification assays: analysis of preanalytical and analytical variables and identification of candidate parameters for seed quantification 107
Clinical, neuropathological, and molecular characteristics of rapidly progressive dementia with Lewy bodies: a distinct clinicopathological entity? 107
RT-QuIC Detection of Pathological α-Synuclein in Skin Punches of Patients with Lewy Body Disease 107
Phenotypic Heterogeneity of Variably Protease-Sensitive Prionopathy: A Report of Three Cases Carrying Different Genotypes at PRNP Codon 129 107
Sporadic Creutzfeldt-Jakob disease VM1: phenotypic and molecular characterization of a novel subtype of human prion disease 106
Cognitive effects of Lewy body pathology in clinically unimpaired individuals 106
Survival of dialysis patients with restless legs syndrome: A 15-year follow-up study 105
Prion-related peripheral neuropathy in sporadic Creutzfeldt-Jakob disease 105
Remitting Tics and Narcolepsy Overlap Associated with Streptococcal Infection: A Case Report 104
Human prion disease: molecular pathogenesis, and possible therapeutic targets and strategies 103
On the road for a single and reliable objective assessment of sleepiness. 103
null 103
Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson’s disease and dementia with Lewy bodies 102
Diagnostic Value of the CSF α-Synuclein Real-Time Quaking-Induced Conversion Assay at the Prodromal MCI Stage of Dementia With Lewy Bodies 101
Defining the phenotypic spectrum of sporadic Creutzfeldt–Jakob disease MV2K: the kuru plaque type 97
Diagnostic and prognostic value of cerebrospinal fluid SNAP-25 and neurogranin in Creutzfeldt-Jakob disease in a clinical setting cohort of rapidly progressive dementias 97
Csf ubiquitin levels are higher in alzheimer’s disease than in frontotemporal dementia and reflect the molecular subtype in prion disease 97
null 96
CSF markers of neurodegeneration Alzheimer's and Lewy body pathology in isolated REM sleep behavior disorder 95
Alpha-synuclein RT-QuIC assay in gastroduodenal and skin biopsies of Parkinson disease patients 93
Prodynorphin and Proenkephalin in Cerebrospinal Fluid of Sporadic Creutzfeldt–Jakob Disease 93
Dementia-related genetic variants in an Italian population of early-onset Alzheimer’s disease 90
α-Synuclein RT-QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies 88
Gerstmann-Straüssler-Scheinker disease (PRNP p.D202N) presenting with atypical parkinsonism 84
Multiple variants in families with amyotrophic lateral sclerosis and frontotemporal dementia related to C9orf72 repeat expansion: further observations on their oligogenic nature 83
Diagnostic and prognostic performance of CSF α-synuclein in prion disease in the context of rapidly progressive dementia 83
A quantitative Lewy-fold-specific alpha-synuclein seed amplification assay as a progression marker for Parkinson's disease 83
α-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burden 82
Early onset sleep disorders predict severity, progression and death in multiple system atrophy 82
High diagnostic performance of plasma and cerebrospinal fluid beta‐synuclein for sporadic Creutzfeldt–Jakob disease 80
Phenotypic diversity of genetic Creutzfeldt–Jakob disease: a histo-molecular-based classification 73
The Use of Real-Time Quaking-Induced Conversion for the Diagnosis of Human Prion Diseases 72
Role of Blood P-Tau Isoforms (181, 217, 231) in Predicting Conversion from MCI to Dementia Due to Alzheimer's Disease: A Review and Meta-Analysis 69
The In Vivo Diagnosis of Concomitant Alzheimer and Lewy Body Pathology: A Case Report 68
Rapidly progressive dementia due to intravascular lymphoma: A prion disease reference center experience 67
Reactive microglia partially envelop viable neurons in prion diseases 58
Evaluation of the impact of CSF prion RT-QuIC and amended criteria on the clinical diagnosis of Creutzfeldt-Jakob disease: a 10-year study in Italy 54
Technique and Preliminary Analysis of Drug-Induced Sleep Endoscopy With Online Polygraphic Cardiorespiratory Monitoring in Patients With Obstructive Sleep Apnea Syndrome. 53
Misfolded α-Synuclein Assessment in the Skin and CSF by RT-QuIC in Isolated REM Sleep Behavior Disorder 52
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum 42
MRI Signature of α-Synuclein Pathology in Asymptomatic Stages and a Memory Clinic Population 40
Unsuccessful transmissions of atypical genetic Creutzfeldt-Jakob disease (PRNP p.T183A-129M) in transgenic mice 38
Perspectives Toward the Development of Quantitative Seed Amplification Assays for α-Synuclein 37
null 29
PrP proteinopathies 29
Inside the clinical evaluation of sleepiness: subjective and objective tools 21
Posterior hippocampal stroke presenting with transient global amnesia 13
Totale 11.558
Categoria #
all - tutte 33.997
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.997


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021693 0 0 0 0 0 39 70 86 83 44 28 343
2021/20221.033 55 35 48 35 113 44 16 120 63 95 212 197
2022/20231.317 117 147 62 130 119 107 54 62 233 48 153 85
2023/2024589 18 66 47 69 56 82 16 71 26 60 49 29
2024/20252.296 102 227 172 129 222 123 204 79 61 246 173 558
2025/20264.004 840 821 793 537 736 277 0 0 0 0 0 0
Totale 11.558